Prostatis Group’s Vanguard FTSE Emerging Markets ETF VWO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,677
Closed -$774K 157
2024
Q2
$774K Sell
17,677
-1,802
-9% -$77.6K 0.27% 78
2024
Q1
$814K Buy
+19,479
New +$795K 0.31% 72
2023
Q4
Sell
-34,371
Closed -$1.35M 142
2023
Q3
$1.35M Sell
34,371
-50,944
-60% -$2.08M 0.66% 35
2023
Q2
$121K Buy
+85,315
New +$3.44M 0.06% 130
2023
Q1
Sell
-13,654
Closed -$532K 115
2022
Q4
$532K Buy
+13,654
New +$521K 0.32% 61
2021
Q1
Sell
-20,112
Closed -$1.01M 101
2020
Q4
$1.01M Sell
20,112
-30,651
-60% -$1.44M 0.84% 26
2020
Q3
$2.19M Buy
+50,763
New +$2.21M 2.08% 15

Other funds holding VWO

Prostatis Group's VWO Position: Q3 2024 in Review

Prostatis Group sold out of Vanguard FTSE Emerging Markets ETF (VWO) in Q3 2024, closing a stake of 17,677 shares — an estimated $774K sold.

Prostatis Group first reported a position in VWO in Q3 2020 and held it in 7 quarters. The position peaked at $2.19M in Q3 2020. 2,086 funds tracked by Wall St. Rank hold VWO as of Q3 2024.

  • Prostatis Group reported no remaining Vanguard FTSE Emerging Markets ETF position as of Q3 2024 after selling out during the quarter.
  • Prostatis Group sold 17,677 Vanguard FTSE Emerging Markets ETF shares in Q3 2024, an estimated $774K.
  • Prostatis Group first reported a position in Vanguard FTSE Emerging Markets ETF in Q3 2020 and held it in 7 quarters.
  • Prostatis Group's Vanguard FTSE Emerging Markets ETF position peaked at $2.19M in Q3 2020.
  • 2,086 funds tracked by Wall St. Rank held Vanguard FTSE Emerging Markets ETF as of Q3 2024.

Based on Prostatis Group's 13F filing for Q3 2024, filed 21 Mar 2025.